Zachary Wallace, MD, MSc

Massachusetts General Hospital
Newton, MA, United States

Dr. Wallace is a rheumatologist and clinical researcher at Massachusetts General Hospital and Harvard Medical School. His clinical and research interests are in vasculitis, IgG4-related disease, and COVID-19. He is a member of the Clinical Epidemiology Program and Co-Director of the Rheumatology Vasculitis Program in the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital. His research has been funded by the NIH, Rheumatology Research Foundation, industry, philanthropy, and Mass General Hospital. He is a member of the Finance Committee of the ACR and a former Chair of RheumPAC.

Disclosure information not submitted.

Presentation(s):

• Models of Mentorship in a COVID World – Opportunities and Challenges

  Thursday, November 10, 2022
  12:15 PM – 12:25 PM Eastern Time

• Q&A

  Thursday, November 10, 2022
  12:25 PM – 12:30 PM Eastern Time

• 0446: The Burden of Coronary Artery Calcification in ANCA-Associated Vasculitis

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1205: Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases

  Saturday, November 12, 2022
  2:15 PM – 2:20 PM Eastern Time

• 0700: Accurate Identification of ANCA-Associated Vasculitis Cases from Clinical Notes Using Machine Learning

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0713: The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1087: Identification of Novel Proteomic Biomarkers of Disease Activity in ANCA-Associated Vasculitis Using a High Throughput Approach

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1091: IgG Antibody Subclass Glycan Modifications in Patients with ANCA-Associated Vasculitis in Active vs Remission States – a Proof-of-Concept Study

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1087: Identification of Novel Proteomic Biomarkers of Disease Activity in ANCA-Associated Vasculitis Using a High Throughput Approach

  Sunday, November 13, 2022
  10:20 AM – 10:25 AM Eastern Time

• 1205: Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 0713: The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States

  Sunday, November 13, 2022
  2:30 PM – 2:35 PM Eastern Time